Stock Events

Stock Events

Kymera Therapeutics (KYMR) Q3 2023 Earnings

2NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-0.9

-0.8

-0.7

-0.6

Details

Expected EPS

-0.72

Actual EPS

-0.9

Surprise EPS

-0.18

Surprise Percent

+25%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.9 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.